Advances towards gastric cancer screening: Novel devices and biomarkers
Best Practice & Research Clinical Gastroenterology · 2025-03 · 75 · 102009
DOI: 10.1016/j.bpg.2025.102009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Best Practice & Research Clinical Gastroenterology, 2025-03. Verfasst von Catarina Lopes und 1 weiteren Autor:innen. Beteiligte Einrichtung: Precancerous Lesions and Early Cancer Management Group, Research Centre of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Group), Portuguese Insti…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Early Detection of Cancer, Biomarkers, Tumor. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: HORIZON EUROPE Health, UK Research and Innovation, European Health and Digital Executive Agency.
Abstract (Originalsprache)
Gastric cancer is a pressing global health issue that ranks fifth as the most commonly diagnosed malignancy and leading cause of cancer-related deaths. Early detection is critical for improving patient outcomes, with five-year survival rates exceeding 90 % when diagnosed at initial stages. Current screening modalities, primarily reliant on upper gastrointestinal endoscopy, are highly accurate, but not without limitations, such as invasiveness, high cost, low adherence and accessibility. Hence, this review aligns with the ongoing efforts to answer the pressing need for innovative approaches, emphasising novel devices and biomarker advancements over the last decade. We highlight non-endoscopic methods such as magnetically controlled capsule endoscopy and point-of-care testing. Additionally, we will provide an overview into the field of liquid biopsies and emerging biomarkers in GC detection, towards accurate, less invasive and costly screening tools that hold the promise for greater accessibility and citizen involvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Precancerous Lesions and Early Cancer Management Group, Research Centre of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Group), Portuguese Institute of Oncology of Porto (IPO Porto)/Porto Comprehensive Cancer Centr…
Förderung
- HORIZON EUROPE Health
- UK Research and Innovation
- European Health and Digital Executive Agency
- European Social Fund Plus
- Ministério da Ciência, Tecnologia e Ensino Superior
- European Commission
- Foundation for Science and Technology
Zitieren
APA
Lopes, C., & Pereira, C. (2025). Advances towards gastric cancer screening: Novel devices and biomarkers. Best Practice & Research Clinical Gastroenterology, 75, 102009. https://doi.org/10.1016/j.bpg.2025.102009
Vancouver
Lopes C, Pereira C. Advances towards gastric cancer screening: Novel devices and biomarkers. Best Practice & Research Clinical Gastroenterology. 2025;75:102009. doi:10.1016/j.bpg.2025.102009
BibTeX
@article{Lopes2025,
author = {Lopes, Catarina and Pereira, Carina},
title = {Advances towards gastric cancer screening: Novel devices and biomarkers},
journal = {Best Practice & Research Clinical Gastroenterology},
year = {2025},
volume = {75},
pages = {102009},
doi = {10.1016/j.bpg.2025.102009}
}
EUVIMED